DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elspar (Asparaginase) - News

 
 



News related to Elspar (Asparaginase) and/or conditions it is approved for

Volasertib Phase II data published including new overall survival results in older patients with acute myeloid leukemia
Source: Clinical Trials / Drug Trials News From Medical News Today [2014.07.10]
Results from a Phase II study that compared volasertib plus low-dose cytarabine (LDAC), a form of chemotherapy, versus LDAC alone in older patients with untreated acute myeloid leukemia (AML) were...

The leukemia battle aided by lipids
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.06.18]
T cells use a novel mechanism to fight leukemia. They may recognize unique lipids produced by cancer cells and kill tumor cells expressing these lipid molecules.

Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Source: MedicineNet Leukemia Specialty [2014.06.09]
Title: Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Category: Health News
Created: 6/6/2014 12:35:00 PM
Last Editorial Review: 6/9/2014 12:00:00 AM

Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Source: Compliance News From Medical News Today [2014.06.04]
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse...

Leukemia
Source: MedicineNet Bladder Cancer Specialty [2014.05.08]
Title: Leukemia
Category: Diseases and Conditions
Created: 8/2/2013 2:36:00 PM
Last Editorial Review: 5/8/2014 12:00:00 AM

New Drug Combo Might Help Older, Sicker Patients With Leukemia
Source: MedicineNet rituximab Specialty [2014.01.10]
Title: New Drug Combo Might Help Older, Sicker Patients With Leukemia
Category: Health News
Created: 1/9/2014 2:35:00 PM
Last Editorial Review: 1/10/2014 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

Ibrutinib and Idelalisib Coming to Europe Soon
Source: Medscape Hematology-Oncology Headlines [2014.07.25]
These 2 novel targeted agents are recommended for approval for chronic lymphocytic leukemia, and also for certain types of lymphoma.
International Approvals

ABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.06.16]
Chronic Lymphocytic Leukaemia (CLL) is the most common leukemia in adults in the Western world and is diagnosed in approximately 5 persons per 100,000 population per year.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014